Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
about
Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion ModelDrug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.Insights into direct nose to brain delivery: current status and future perspective.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Intranasal delivery: circumventing the iron curtain to treat neurological disorders.Novel anionic polymer as a carrier for CNS delivery of anti-Alzheimer drug.Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.Optimization of artemether-loaded NLC for intranasal delivery using central composite design.Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation.Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization.Increased brain uptake of venlafaxine loaded solid lipid nanoparticles by overcoming the efflux function and expression of P-gp.Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.
P2860
Q34339313-2853FEE4-CB65-4761-840F-35D2F6B5B31AQ37306876-3052B656-C18B-495F-BBFB-D47A66273252Q38075010-D7606186-C5BD-4264-B66C-80A74D01D206Q38150429-9464F6B3-17D4-4218-AEA5-DD83088A81F8Q38522125-315C4B79-1492-4676-9498-E847E9412C93Q38553213-383AB30D-A754-4729-92BA-EA2F254004E3Q38767236-324E38E6-794E-4488-BCFF-A55BA64446DFQ38899961-080583AE-233D-4AD1-98D9-7DDFF16A2CDBQ38937398-7A1B6688-4081-48E0-9D9E-EAE092672702Q39025443-2357637F-CC6F-43DB-A3E6-B32F69D512BEQ42005180-B6BE4EA0-1884-4730-B485-52FBD5ABD20EQ47893114-980D7D7D-5922-4E5A-96C8-E8D9E9B9D6A2Q48187795-4C4EB918-6EFA-4C96-9857-4386FB4FFA40Q48387140-AF1B1879-116F-435D-AF62-A068846CAB6CQ48417067-B32EEBA3-2BC5-4C60-A667-F90B5D36426DQ48477773-0561310A-5B35-4B70-9DD3-6C24D0057FFBQ48580295-14206045-2D5B-4EFD-8281-681DFFDEF2DEQ52654049-6D99B0A9-8764-46B8-ABA5-BFA7D125E2B5
P2860
Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@ast
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@en
type
label
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@ast
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@en
prefLabel
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@ast
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@en
P2093
P50
P1476
Venlafaxine loaded chitosan NP ...... nd pharmacodynamic evaluation.
@en
P2093
Jasjeet Kaur Sahni
Manish Kumar
Mohammad Fazil
P356
10.1016/J.CARBPOL.2012.02.051
P577
2012-02-28T00:00:00Z